Post #3908

🇺🇸🇨🇳Nvidia's AI Drug Lab Launch Fails to Boost Stock Nvidia is investing $1 billion over five years to create an AI drug discovery lab with Eli Lilly. The Silicon Valley facility will merge Lilly's lab expertise with Nvidia's AI capabilities. This collaboration aims to automate research and accelerate drug development. Despite the announcement of the AI lab and a collaboration with Thermo Fisher Scientific, Nvidia's stock shows stability to a slight decline. Investors remain focused on Nvidia's core AI chip sales, particularly progress in China, as markets await regulatory clarity regarding H200 chips and Chinese demand. Minas Tirith | 24/7 News channel | Updated